These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 21831495)
1. What's at stake? Genetic information from the perspective of people with epilepsy and their family members. Shostak S; Zarhin D; Ottman R Soc Sci Med; 2011 Sep; 73(5):645-54. PubMed ID: 21831495 [TBL] [Abstract][Full Text] [Related]
2. "It's good to know": experiences of gene identification and result disclosure in familial epilepsies. Vears DF; Dunn KL; Wake SA; Scheffer IE Epilepsy Res; 2015 May; 112():64-71. PubMed ID: 25847340 [TBL] [Abstract][Full Text] [Related]
3. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. American Society of Clinical Oncology J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171 [TBL] [Abstract][Full Text] [Related]
5. Ethical, legal, and social dimensions of epilepsy genetics. Shostak S; Ottman R Epilepsia; 2006 Oct; 47(10):1595-602. PubMed ID: 17054679 [TBL] [Abstract][Full Text] [Related]
6. Palliative care experiences of adult cancer patients from ethnocultural groups: a qualitative systematic review protocol. Busolo D; Woodgate R JBI Database System Rev Implement Rep; 2015 Jan; 13(1):99-111. PubMed ID: 26447011 [TBL] [Abstract][Full Text] [Related]
7. Managing self-responsibility through other-oriented blame: family accounts of genetic testing. Arribas-Ayllon M; Sarangi S; Clarke A Soc Sci Med; 2008 Apr; 66(7):1521-32. PubMed ID: 18222583 [TBL] [Abstract][Full Text] [Related]
8. Stakeholder Perspectives on Overcoming Barriers to Cascade Testing in Lynch Syndrome: A Qualitative Study. Srinivasan S; Hampel H; Leeman J; Patel A; Kulchak Rahm A; Reuland DS; Roberts MC Cancer Prev Res (Phila); 2020 Dec; 13(12):1037-1046. PubMed ID: 32727822 [TBL] [Abstract][Full Text] [Related]
9. Disclosing genetic test results to family members. Hamilton RJ; Bowers BJ; Williams JK J Nurs Scholarsh; 2005; 37(1):18-24. PubMed ID: 15813582 [TBL] [Abstract][Full Text] [Related]
10. Protocol for stage 1 of the GaP study (Genetic testing acceptability for Paget's disease of bone): an interview study about genetic testing and preventive treatment: would relatives of people with Paget's disease want testing and treatment if they were available? Langston AL; Johnston M; Robertson C; Campbell MK; Entwistle VA; Marteau TM; McCallum M; Ralston SH BMC Health Serv Res; 2006 Jun; 6():71. PubMed ID: 16762063 [TBL] [Abstract][Full Text] [Related]
12. Perceptions of genetic research and testing among members of families with an increased risk of malignant melanoma. Bränström R; Kasparian NA; Affleck P; Tibben A; Chang YM; Azizi E; Baron-Epel O; Bergman W; Chan M; Davies J; Ingvar C; Kanetsky PA; van Leeuwen E; Olsson H; Gruis NA; Brandberg Y; Newton-Bishop J Eur J Cancer; 2012 Nov; 48(16):3052-62. PubMed ID: 22726816 [TBL] [Abstract][Full Text] [Related]
13. Genetic causal attribution of epilepsy and its implications for felt stigma. Sabatello M; Phelan JC; Hesdorffer DC; Shostak S; Goldsmith J; Sorge ST; Winawer MR; Chung WK; Ottman R Epilepsia; 2015 Oct; 56(10):1542-50. PubMed ID: 26290354 [TBL] [Abstract][Full Text] [Related]
14. African American Living Donors' Attitudes About APOL1 Genetic Testing: A Mixed Methods Study. Gordon EJ; Amόrtegui D; Blancas I; Wicklund C; Friedewald J; Sharp RR Am J Kidney Dis; 2018 Dec; 72(6):819-833. PubMed ID: 30360961 [TBL] [Abstract][Full Text] [Related]
15. Genetic testing for inflammatory bowel disease: focus group analysis of patients and family members. Lewis JR; Konda V; Rubin DT Genet Test Mol Biomarkers; 2009 Aug; 13(4):495-503. PubMed ID: 19580441 [TBL] [Abstract][Full Text] [Related]
16. Public perception of predictive cancer genetic testing and research in Oregon. Alvord TW; Marriott LK; Nguyen PT; Shafer A; Brown K; Stoller W; Volpi JL; Vandehey-Guerrero J; Ferrara LK; Blakesley S; Solomon E; Kuehl H; Palma AJ; Farris PE; Hamman KJ; Cotter M; Shannon J J Genet Couns; 2020 Apr; 29(2):259-281. PubMed ID: 32220044 [TBL] [Abstract][Full Text] [Related]
17. Developmental and epileptic encephalopathy: Personal utility of a genetic diagnosis for families. Jeffrey JS; Leathem J; King C; Mefford HC; Ross K; Sadleir LG Epilepsia Open; 2021 Mar; 6(1):149-159. PubMed ID: 33681658 [TBL] [Abstract][Full Text] [Related]
18. Implications for families of advances in understanding the genetic basis of epilepsy. Hammond CL; Thomas RH; Rees MI; Kerr MP; Rapport F Seizure; 2010 Dec; 19(10):675-9. PubMed ID: 21095138 [TBL] [Abstract][Full Text] [Related]
19. Breast Cancer Risk Perceptions among Relatives of Women with Uninformative Negative BRCA1/2 Test Results: The Moderating Effect of the Amount of Shared Information. Himes DO; Clayton MF; Donaldson GW; Ellington L; Buys SS; Kinney AY J Genet Couns; 2016 Apr; 25(2):258-69. PubMed ID: 26245632 [TBL] [Abstract][Full Text] [Related]
20. Perceptions of genetic testing in patients with hereditary chronic pancreatitis and their families: a qualitative triangulation. Müller R; Aghdassi AA; Kruse J; Lerch MM; Simon P; Salloch S Eur J Hum Genet; 2021 Jan; 29(1):29-38. PubMed ID: 32788661 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]